Adaptability clinical trail of angina pectorias treated with xinxuekang capsule

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-09000332

Enrollment

Unknown

Registered

2009-01-08

Start date

2009-02-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease (Angina)

Interventions

experiment:Xin Xue Kang capsule

comparison:Compound Danshen pill

Eligibility

Sex/Gender

All

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with angina of effort and stable angina cordis disease of effort I, II, III stage; be the TCM signs of "Xue Yu" (blood stasis syndrome); Age 40~70 years old; the test-receiver know what happened, and sign informed consent.

Exclusion criteria

Exclusion criteria: Who expirenced heart interventional therapy and after CABG operation; Pregnancy or suckling women; Allergic physical endowment and allergy to various medicine; Who attend other clinical trial in last a month.

Design outcomes

Primary

Measure	Time frame
remission of angina attack;cardiograph;	—

Secondary

Measure	Time frame
blood lipides concentration;Change of TCM sign;	—

Countries

China

Contacts

Public ContactWang Zhong

zhonw@sina.com+86 0 13601315446

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026